Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-12-19 Purchase |
2024-12-20 8:00 pm |
Tharimmune Inc. | THAR | MILBY RANDY CEO |
4,600 | $2.12 | $9,752 | 17,534 (Direct) |
View |
2024-11-13 Purchase |
2024-11-13 5:06 pm |
Tharimmune Inc. | THAR | Appajosyula Sireesh Chief Operating Officer |
5,000 | $2.0192 | $10,096 | 13,372 (Indirect Direct) |
View |
2024-10-08 Purchase |
2024-10-10 4:15 pm |
Tharimmune Inc. | THAR | MILBY RANDY CEO |
2,500 | $2.0884 | $5,221 | 12,934 (Direct) |
View |
2024-10-08 Purchase(A) |
2024-10-09 09:58 am |
Tharimmune Inc. | THAR | Appajosyula Sireesh Chief Operating Officer |
5,000 | $1.93 | $9,650 | 8,372 (Indirect Direct) |
View |
2024-10-08 Purchase |
2024-10-08 4:10 pm |
Tharimmune Inc. | THAR | Appajosyula Sireesh Chief Operating Officer |
5,000 | $1.93 | $9,650 | 55,557 (Indirect Direct) |
View |
2023-12-15 Purchase |
2023-12-18 10:04 am |
Tharimmune Inc. | THAR | MILBY RANDY CEO |
29,000 | $0.503 | $14,587 | 156,517 (Direct) |
View |
2023-11-30 Purchase |
2023-12-04 4:15 pm |
Tharimmune Inc. | THAR | MILBY RANDY CEO |
10,000 | $1 | $10,000 | 127,517 (Direct) |
View |
2022-06-17 Purchase |
2022-06-21 4:15 pm |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer 10% Owner |
500 | $0.7799 | $390 | 2,937,940 (Direct) |
View |
2022-06-06 Purchase |
2022-06-07 4:15 pm |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
1,000 | $0.68846 | $688 | 2,938,540 (Direct) |
View |
2022-06-01 Purchase |
2022-06-02 4:15 pm |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
1 | $0.94 | $1 | 2,937,540 (Direct) |
View |
2022-05-25 Purchase |
2022-05-25 5:28 pm |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
1,000 | $0.786 | $786 | 2,937,539 (Direct) |
View |
2022-05-20 Purchase |
2022-05-23 4:15 pm |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
1,000 | $0.91825 | $918 | 2,936,539 (Direct) |
View |
2022-05-19 Purchase |
2022-05-19 4:59 pm |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
1,000 | $0.90765 | $908 | 2,935,539 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-13 Option Award |
2025-01-14 4:47 pm |
N/A 2035-01-13 |
Tharimmune Inc. | THAR | MILBY RANDY CEO |
80,958 | $0 | 138,665 (Direct) |
View |
2025-01-13 Option Award |
2025-01-14 4:38 pm |
N/A 2035-01-13 |
Tharimmune Inc. | THAR | Appajosyula Sireesh Chief Operating Officer |
52,875 | $0 | 115,962 (Direct) |
View |
2024-08-09 Option Award |
2024-08-12 5:18 pm |
N/A 2034-08-09 |
Tharimmune Inc. | THAR | Anderson Kelly Director |
2,353 | $0 | 52,353 (Direct) |
View |
2024-08-09 Option Award |
2024-08-12 5:18 pm |
N/A 2034-08-09 |
Tharimmune Inc. | THAR | Appajosyula Sireesh Chief Operating Officer |
38,087 | $0 | 63,087 (Direct) |
View |
2024-08-09 Option Award |
2024-08-12 5:18 pm |
N/A 2034-08-09 |
Tharimmune Inc. | THAR | Mazur Leonard L Director |
2,353 | $0 | 27,353 (Direct) |
View |
2024-08-09 Option Award |
2024-08-12 5:17 pm |
N/A 2034-08-09 |
Tharimmune Inc. | THAR | MILBY RANDY CEO |
57,707 | $0 | 57,707 (Direct) |
View |
2024-08-09 Option Award |
2024-08-12 5:17 pm |
N/A 2034-08-09 |
Tharimmune Inc. | THAR | Bui Lynne A. Director |
2,353 | $0 | 27,353 (Direct) |
View |
2023-11-07 Option Award |
2023-11-09 7:55 pm |
N/A 2033-11-07 |
Tharimmune Inc. | THAR | Bui Lynne A. Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-11-07 Option Award |
2023-11-09 7:52 pm |
N/A 2033-11-07 |
Tharimmune Inc. | THAR | Appajosyula Sireesh Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-11-07 Option Award |
2023-11-09 7:51 pm |
N/A 2033-11-07 |
Tharimmune Inc. | THAR | Anderson Kelly Director |
50,000 | $0 | 50,000 (Direct) |
View |
2023-11-07 Option Award |
2023-11-09 7:48 pm |
N/A 2033-11-07 |
Tharimmune Inc. | THAR | Mazur Leonard L Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-01-01 Option Award(A) |
2023-03-13 4:17 pm |
2023-01-01 2033-01-01 |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer 10% Owner |
515,127 | $0 | 515,127 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 5:43 pm |
2023-01-01 2033-01-01 |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer 10% Owner |
621,795 | $0 | 621,795 (Direct) |
View |
2022-07-14 Gift |
2022-07-18 4:15 pm |
N/A N/A |
Hillstream BioPharma Inc. | HILS | Appajosyula Sireesh Director |
83,333 | $0 | 7,576 (Indirect) |
View |
2022-04-18 Exercise |
2022-04-19 08:05 am |
N/A N/A |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
7,575 | $0.314 | 2,944,009 (Direct) |
View |
2022-04-18 Exercise |
2022-04-19 08:05 am |
2020-02-29 2030-02-28 |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
240,526 | $0 | 2,944,009 (Direct) |
View |
2022-04-18 Exercise |
2022-04-19 08:05 am |
N/A N/A |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
217,801 | $0.079 | 2,944,009 (Direct) |
View |
Ownership(A) |
2022-04-19 08:00 am |
N/A 2023-06-20 |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
0 | $0 | 117,986 (Direct) |
View |
2022-03-21 Option Award |
2022-03-23 4:15 pm |
N/A 2032-03-21 |
Hillstream BioPharma Inc. | HILS | Mazur Leonard L Director |
50,000 | $0 | 50,000 (Direct) |
View |
2022-03-21 Option Award |
2022-03-23 4:15 pm |
N/A 2032-03-21 |
Hillstream BioPharma Inc. | HILS | Bui Lynne A. Director |
50,000 | $0 | 50,000 (Direct) |
View |
2022-03-21 Option Award |
2022-03-23 4:15 pm |
N/A 2032-03-21 |
Hillstream BioPharma Inc. | HILS | Appajosyula Sireesh Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2022-01-27 06:03 am |
N/A N/A |
Hillstream BioPharma Inc. | HILS | Kaur Varinder 10% Owner |
0 | $0 | 653,059 (Direct) |
View |
2022-01-14 Conversion |
2022-01-20 09:26 am |
N/A N/A |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
864,490 | $0 | 3,451,588 (Direct) |
View |
2022-01-14 Option Award |
2022-01-20 09:26 am |
N/A 2032-01-14 |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
757,575 | $0 | 3,451,588 (Direct) |
View |
2022-01-14 Conversion |
2022-01-20 09:26 am |
N/A N/A |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
276,289 | $3.2 | 3,451,588 (Direct) |
View |
2022-01-14 Conversion |
2022-01-20 09:25 am |
N/A N/A |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
793,702 | $0 | 2,417,724 (Direct) |
View |
2022-01-14 Conversion |
2022-01-20 09:25 am |
N/A N/A |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
260,674 | $3.2 | 2,417,724 (Direct) |
View |
2022-01-14 Conversion |
2022-01-20 09:23 am |
N/A N/A |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
1,146,126 | $0 | 2,157,050 (Direct) |
View |
2022-01-14 Conversion |
2022-01-20 09:23 am |
N/A N/A |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer |
384,325 | $3.2 | 2,157,050 (Direct) |
View |
Ownership(A) |
2022-01-20 09:21 am |
N/A N/A |
Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer 10% Owner |
0 | $0 | 1,772,725 (Direct) |
View |